ライフサイエンスコーパス: evaluate the efficacy

1 To evaluate the efficacy and mechanism of nitrite in metabo

2 To evaluate the efficacy and ocular and systemic safety of

3 as followed by an expanded cohort to further evaluate the efficacy and safety at the MTD.

4 ion, and dosimetry studies were performed to evaluate the efficacy and safety of (64)Cu-DOTA-alendron

5 hase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib

6 To evaluate the efficacy and safety of 25- and 50-mg/d dosa

7 24-week, multicenter trial was conducted to evaluate the efficacy and safety of 3 doses of ABT-126,

8 Purpose To evaluate the efficacy and safety of a clofarabine-based

9 The authors sought to evaluate the efficacy and safety of ABT-126, a selective

10 To evaluate the efficacy and safety of ADS-5102 (amantadine

11 We sought to evaluate the efficacy and safety of allergen-specific im

12 The purpose of this study was to evaluate the efficacy and safety of an OC000459 monother

13 This study sought to evaluate the efficacy and safety of cangrelor compared w

14 my, active-controlled trial was conducted to evaluate the efficacy and safety of COBI versus ritonavi

15 Our objectives were to evaluate the efficacy and safety of coronary sinus aspir

16 rrent investigator-led trial was designed to evaluate the efficacy and safety of DAA, in combination

17 The goal of this study was to evaluate the efficacy and safety of DAPT after DES impla

18 d subgroup analysis of MEAD study results to evaluate the efficacy and safety of DEX 0.7 treatment in

19 To evaluate the efficacy and safety of dexamethasone (DEX)

20 Monitoring these subsets could help to evaluate the efficacy and safety of DMF treatment.

21 We sought to evaluate the efficacy and safety of eOIT in participants

22 To evaluate the efficacy and safety of eravacycline compare

23 In this study, we aim to evaluate the efficacy and safety of exercise training in

24 We aimed to evaluate the efficacy and safety of foretinib in patient

25 We sought to evaluate the efficacy and safety of grass pollen intrade

26 We sought to evaluate the efficacy and safety of GSK679586 in patient

27 controlled, phase 3 study in 18 countries to evaluate the efficacy and safety of HZ/su in older adult

28 a multicenter, open-label, phase 2 study to evaluate the efficacy and safety of ibrutinib in previou

29 tive and controlled studies are necessary to evaluate the efficacy and safety of innovative anti-noro

30 We performed a meta-analysis to evaluate the efficacy and safety of intensive BP reducti

31 We performed a phase 3 study to evaluate the efficacy and safety of intravenous terlipre

32 Herein we prospectively evaluate the efficacy and safety of intravitreal afliber

33 bel nonrandomized phase 3 trial conducted to evaluate the efficacy and safety of ISAV treatment in ma

34 cebo-controlled, phase 3, crossover trial to evaluate the efficacy and safety of ivacaftor alone or i

35 We performed a phase 2 clinical trial to evaluate the efficacy and safety of ledipasvir and sofos

36 a phase 2, multicenter, open-label study to evaluate the efficacy and safety of ledipasvir-sofosbuvi

37 The primary goal of the AREDS2 was to evaluate the efficacy and safety of lutein plus zeaxanth

38 ploratory, randomized, single-blind trial to evaluate the efficacy and safety of moxidectin (8 mg) vs

39 domized clinical trials are needed to better evaluate the efficacy and safety of newer glaucoma proce

40 We performed a phase II study to evaluate the efficacy and safety of pertuzumab and trast

41 The objective of this study was to evaluate the efficacy and safety of pharmacological and

42 o-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of prucalopride in chil

43 To evaluate the efficacy and safety of ranibizumab 0.5 mg t

44 (A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Chil

45 We conducted a phase 3 open-label study to evaluate the efficacy and safety of ruxolitinib versus s

46 We conducted a trial to evaluate the efficacy and safety of scheduled intermitte

47 We sought to evaluate the efficacy and safety of secukinumab, an anti

48 o-controlled, dose-ranging, phase 3 trial to evaluate the efficacy and safety of self-administered su

49 This study sought to evaluate the efficacy and safety of subcutaneous evolocu

50 d, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous omalizu

51 We sought to systematically evaluate the efficacy and safety of systemic treatments

52 d, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the combination of s

53 The purpose of this study was to evaluate the efficacy and safety of transcatheter aortic

54 a multicenter, open-label, phase 3 trial to evaluate the efficacy and safety of treatment with the c

55 o-controlled, phase 3, double-blind trial to evaluate the efficacy and safety of vedolizumab, an anti

56 To evaluate the efficacy and safety of XG-102 (brimapitide)

57 multicentre, clinical trial was performed to evaluate the efficacy and safety of xyloglucan, in compa

58 To evaluate the efficacy and safety of Zephyr EBVs in patie

59 Further studies are needed to evaluate the efficacy and safety of zirconium cyclosilic

60 To evaluate the efficacy and the mechanisms of action of CD

61 To evaluate the efficacy and tolerability of alpha-galactos

62 We aimed to evaluate the efficacy and tolerability of modafinil in t

63 international, multicenter phase II trial to evaluate the efficacy and toxicity of fractionated (90)Y

64 The authors evaluated the efficacy and durability of a therapist-sup

65 This study evaluated the efficacy and immunologic mechanisms of a v

66 single-arm study (OPTIMIST-2 [NCT02114151]) evaluated the efficacy and safety of 12 weeks of simepre

67 This randomized, double-blind trial evaluated the efficacy and safety of 16 weeks of treatme

68 s multicenter, open-label, phase 2 study, we evaluated the efficacy and safety of a fixed-dose combin

69 We evaluated the efficacy and safety of a minimally absorbe

70 Here, we have evaluated the efficacy and safety of a recombinant VSV t

71 We evaluated the efficacy and safety of aCT1 in the reducti

72 present meta-analysis and systematic review evaluated the efficacy and safety of aerosolized colisti

73 We evaluated the efficacy and safety of AMG 145 in an open-

74 tion of gD-2 unmasks protective antigens, we evaluated the efficacy and safety of an HSV-2 virus dele

75 We evaluated the efficacy and safety of an interferon-free

76 , noninferiority (NI), global, phase 3 study evaluated the efficacy and safety of bendamustine plus r

77 This trial evaluated the efficacy and safety of bevacizumab with GC

78 This phase 2, open-label study evaluated the efficacy and safety of brentuximab vedotin

79 This phase 2, open-label, multicenter study evaluated the efficacy and safety of brentuximab vedotin

80 We evaluated the efficacy and safety of buparlisib plus ful

81 Few trials evaluated the efficacy and safety of combination therapi

82 We evaluated the efficacy and safety of daclatasvir + sofos

83 We evaluated the efficacy and safety of DEX implant in the

84 e at increased risk of stroke; therefore, we evaluated the efficacy and safety of different approache

85 This phase III study evaluated the efficacy and safety of earlier treatment w

86 We evaluated the efficacy and safety of edoxaban versus war

87 omized, double-blind, multicenter study that evaluated the efficacy and safety of eravacycline in com

88 rom a phase 2, placebo-controlled study that evaluated the efficacy and safety of etrolizumab in pati

89 ed all prospective intervention studies that evaluated the efficacy and safety of exercise training i

90 This phase 2, open-label study (MAGELLAN-1) evaluated the efficacy and safety of glecaprevir (GLE) +

91 We evaluated the efficacy and safety of high-dose swallowed

92 mized, placebo-controlled, phase 3 trial, we evaluated the efficacy and safety of levosimendan in pat

93 Chemotherapy-Induced Diarrhea (LARCID) trial evaluated the efficacy and safety of long-acting release

94 This study evaluated the efficacy and safety of lurasidone in major

95 The authors evaluated the efficacy and safety of lurasidone in the t

96 This randomized, controlled trial evaluated the efficacy and safety of lutetium-177 ((177)

97 We evaluated the efficacy and safety of multimatrix mesalam

98 dose-escalation, phase I CheckMate 016 study evaluated the efficacy and safety of nivolumab plus ipil

99 ed, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully

100 We evaluated the efficacy and safety of obeticholic acid (O

101 icance of this change, TURQUOISE-I, Part 1b, evaluated the efficacy and safety of OBV/PTV/r + DSV + R

102 We evaluated the efficacy and safety of olaparib in a spect

103 ticenter, randomized, double-blind study, we evaluated the efficacy and safety of omalizumab in patie

104 ticenter, randomized, double-blind trial, we evaluated the efficacy and safety of oral rivaroxaban ad

105 ebo-controlled, dose-finding phase IIb study evaluated the efficacy and safety of ponesimod, an oral

106 The FLIGHT1 and FLIGHT2 studies evaluated the efficacy and safety of QVA149 (indacaterol

107 olled, parallel-group, eight-group study, we evaluated the efficacy and safety of romosozumab over a

108 We prospectively evaluated the efficacy and safety of sofosbuvir-based di

109 This trial evaluated the efficacy and safety of tezepelumab (AMG 15

110 In this phase 3 trial we evaluated the efficacy and safety of the interferon-free

111 mized, placebo-controlled, phase 3 trial, we evaluated the efficacy and safety of the selective CDK4/

112 We evaluated the efficacy and safety of therapy with the no

113 This study evaluated the efficacy and safety of ticagrelor on major

114 risk factors and individual INR control, we evaluated the efficacy and safety of warfarin treatment

115 We evaluated the efficacy and tolerability of 2 combination

116 This study evaluated the efficacy and tolerability of belinostat, a

117 Here, we evaluated the efficacy and tolerability of blinatumomab

118 Remission in Depressed Elderly (PRIDE) study evaluated the efficacy and tolerability of continuation

119 The authors evaluated the efficacy and tolerability of topiramate in

120 We evaluated the efficacy and toxicity of anti-CD45 RIT usi

121 This study evaluated the efficacy and toxicity of second-course OAC

122 This randomized trial evaluated the efficacy and toxicity of sequential gemtuz

123 e authors performed an updated meta-analysis evaluating the efficacy and safety of CAS versus CEA, gi

124 critical for optimizing delivery methods and evaluating the efficacy and safety of cell therapeutics.

125 ort the results of OPUS-2, a phase III study evaluating the efficacy and safety of lifitegrast compar

126 s of OPUS-3 (NCT02284516), a phase III study evaluating the efficacy and safety of lifitegrast versus

127 this symposium), a randomized clinical trial evaluating the efficacy and safety of monthly and PRN do

128 We also did a systematic review of trials evaluating the efficacy and safety of quarter-standard-d

129 aracterizing those mutations is critical for evaluating the efficacy and specificity of targeted geno

130 We sought to evaluate the efficacy, efficiency, and physiologic conse

131 We evaluate the efficacy of 2 newly developed, rice-based c

132 We designed a study to evaluate the efficacy of a 24-week treatment strategy in

133 omized, placebo-controlled trial in Niger to evaluate the efficacy of a live, oral bovine rotavirus p

134 a multisite, randomized controlled trial to evaluate the efficacy of a mobile Web application, Infor

135 To evaluate the efficacy of a nurse-facilitated communicati

136 To evaluate the efficacy of a panel of VEA clinical candida

137 This study aimed to evaluate the efficacy of a specialist training programme

138 olving 88 children with DCD was conducted to evaluate the efficacy of a task-specific balance trainin

139 A randomised controlled trial is needed to evaluate the efficacy of an early invasive approach in p

140 cebo-controlled randomized clinical trial to evaluate the efficacy of antidepressant pharmacotherapy,

141 LA).A2 sensitization was used for studies to evaluate the efficacy of antiYIL-6R on alloantibody reca

142 sults of a bench-scale treatability study to evaluate the efficacy of bioaugmentation with bioamended

143 We sought to evaluate the efficacy of bococizumab in patients at high

144 This meta-analysis aims to evaluate the efficacy of bone marrow-derived mononuclear

145 A subgroup analysis was done to evaluate the efficacy of CA as first- or second-line the

146 r-deficient AG129 mice and used the model to evaluate the efficacy of candidate HFMD vaccines.

147 The primary objective was to evaluate the efficacy of citalopram for agitation in pat

148 ory responses and offer an excellent tool to evaluate the efficacy of compounds designed to therapeut

149 Purpose To evaluate the efficacy of deep convolutional neural netwo

150 tion can potentially be used as biomarker to evaluate the efficacy of different treatment strategies,

151 Although there are several studies to evaluate the efficacy of drugs against CHIKV, the treatm

152 of principle, that this model can be used to evaluate the efficacy of drugs designed to target specif

153 to detect ID-induced brain dysfunction, and evaluate the efficacy of early iron treatment in prevent

154 eosinophilia in peanut-sensitized piglets to evaluate the efficacy of epicutaneous immunotherapy (EPI

155 The authors aimed to evaluate the efficacy of epoetin alfa treatment on the o

156 Shear bond strength testing was performed to evaluate the efficacy of experimental PENTA-containing p

157 a multisite, randomized controlled trial to evaluate the efficacy of exposure to a bilingual, cultur

158 o lay the foundation for a clinical trial to evaluate the efficacy of GSI in esophageal adenocarcinom

159 riple-fused reporter gene system (p21-3H) to evaluate the efficacy of HDACI and the ganciclovir (GCV)

160 eservation, this pilot study is the first to evaluate the efficacy of IGL-1 in pancreas transplantati

161 We aimed to evaluate the efficacy of IIV against serologically diagn

162 The aim of this study is to evaluate the efficacy of IL-2RAb in reducing acute rejec

163 specific antibody concentration in plasma to evaluate the efficacy of immune responses to different r

164 ngle-cell dosimetric approach is required to evaluate the efficacy of individual radionuclides for th

165 To evaluate the efficacy of internet-based guided self-help

166 Thus, our objective was to evaluate the efficacy of intravenous m21G6 treatment in

167 The purpose of study was to evaluate the efficacy of intravitreal injection of 2-Met

168 ; and (4) long-term hydrologic monitoring to evaluate the efficacy of LID interventions.

169 lable endpoints of therapy are inadequate to evaluate the efficacy of many of the new therapeutics.

170 The objective was to evaluate the efficacy of MP-AzeFlu (Dymista((R)) ) vs fl

171 The present study sought to evaluate the efficacy of N-acetylcysteine amide (NACA) e

172 We sought to evaluate the efficacy of nasal filters (Rhinix; Rhinix A

173 This model could be useful to evaluate the efficacy of new therapies and stratify pati

174 We sought to evaluate the efficacy of niraparib versus placebo as mai

175 To evaluate the efficacy of nontransplant surgery for pedia

176 persistent mouse line with liver fibrosis to evaluate the efficacy of novel therapies.

177 tion of human hematopoietic stem cells or to evaluate the efficacy of novel treatment modalities, ste

178 To evaluate the efficacy of omalizumab in AD and to identif

179 The aim of this study is to evaluate the efficacy of omalizumab in severe bronchial

180 The primary objective was to evaluate the efficacy of omalizumab vs placebo at week 2

181 The current study is designed to evaluate the efficacy of open-flap debridement (OFD) com

182 To evaluate the efficacy of our approach, our approach was

183 The objective of this study is to evaluate the efficacy of pace mapping in identifying the

184 a double-blind, placebo-controlled trial to evaluate the efficacy of parenteral methotrexate (25 mg/

185 We have now expanded this study to evaluate the efficacy of PD-1 blockade in patients with

186 erghei murine malaria model may be useful to evaluate the efficacy of PfENT1 inhibitors in vivo and t

187 d to better characterize this phenomenon and evaluate the efficacy of potential interventions.

188 To evaluate the efficacy of propranolol (3 mg/kg/day) in th

189 The aim of this study was to evaluate the efficacy of rectal administration of indome

190 We aimed to evaluate the efficacy of relamorelin on symptoms and gas

191 2013 and 2016 resulted in intense efforts to evaluate the efficacy of several specific countermeasure

192 open-label, randomized, controlled trial to evaluate the efficacy of single-dose primaquine (0.75 mg

193 ate that it may be worthwhile to selectively evaluate the efficacy of SMAC mimetic treatment in CRC p

194 ple juice using fuzzy logic approach, and to evaluate the efficacy of the acceptable concentration in

195 Purpose To evaluate the efficacy of the addition of palifosfamide t

196 To evaluate the efficacy of the Cognitive Behavioral Analys

197 -5, were selected as the model cell lines to evaluate the efficacy of the MIIS method and the importa

198 The purpose of this randomized trial was to evaluate the efficacy of the Mindfulness-Based Stress Re

199 We aimed to evaluate the efficacy of the parenteral (intravenous or

200 goal of prolonging life are not adequate to evaluate the efficacy of these interventions.

201 Further studies are needed to fully evaluate the efficacy of these novel regimens in combina

202 T; prospective studies are required to fully evaluate the efficacy of these novel regimens in combina

203 Clinical trials are now available to evaluate the efficacy of these targeted molecular agents

204 The goal of this phase II study was to evaluate the efficacy of this combination in newly diagn

205 o expand on these preliminary results and to evaluate the efficacy of this intervention in clinical s

206 The aim of this study was to evaluate the efficacy of this modality in a meta-analysi

207 The aim of this analysis was to evaluate the efficacy of topical immunotherapy with 5% I

208 maging are providing additional potential to evaluate the efficacy of treatment while it is being del

209 n a double-blind placebo-controlled trial to evaluate the efficacy of treatment with prednisolone (40

210 ar sorptive extraction (HS-SBSE) was used to evaluate the efficacy of two stir bar coatings, poly(eth

211 Purpose To evaluate the efficacy of ultrasonographically (US)-guide

212 The objective of this study was to evaluate the efficacy of Viscocanalostomy/Phacoviscocana

213 This study evaluated the efficacy of 10-Hz rTMS applied to the left

214 g 84,496 adults 65 years of age or older, we evaluated the efficacy of 13-valent polysaccharide conju

215 This study evaluated the efficacy of a cancer genetics-specific que

216 We evaluated the efficacy of a candidate inactivated quadri

217 We evaluated the efficacy of a pelvic lead shield and a nov

218 We evaluated the efficacy of a telephone-based coping skill

219 This trial evaluated the efficacy of acetaminophen in reducing oxid

220 performant of these siRNAs (siRYR2-U10), we evaluated the efficacy of an adeno-associated serotype 9

221 lating ovarian cancer cell dissemination and evaluated the efficacy of an AURKA-selective small molec

222 This phase II study evaluated the efficacy of bendamustine in relapsed and r

223 In this study, we evaluated the efficacy of birinapant, a small-molecule m

224 This phase 2, open-label study evaluated the efficacy of brentuximab vedotin, an anti-C

225 zed, double-blind, placebo-controlled trials evaluated the efficacy of budesonide foam for induction

226 randomised, double-blind-phase III trial, we evaluated the efficacy of budesonide in the prophylaxis

227 The authors evaluated the efficacy of cognitive-behavioral therapy (

228 Here, we initially evaluated the efficacy of combination MAb therapy in a n

229 RFLOX, and FOXFIRE-Global randomised studies evaluated the efficacy of combining first-line chemother

230 We evaluated the efficacy of everolimus plus bevacizumab in

231 Randomized controlled clinical trials that evaluated the efficacy of exercise training in patients

232 This study evaluated the efficacy of fenofibrate on DR in type 1 di

233 We evaluated the efficacy of fish oil-derived n-3 (omega-3)

234 We evaluated the efficacy of gemcitabine and oxaliplatin ad

235 1) in a large animal model of chronic PH and evaluated the efficacy of gene transfer regarding progre

236 We evaluated the efficacy of HCV core antigen in diagnosing

237 We evaluated the efficacy of hyperimmune globulin in a phas

238 We evaluated the efficacy of ibrutinib, a covalent inhibito

239 We evaluated the efficacy of infliximab in preventing posto

240 We evaluated the efficacy of intravenous LOLA in the revers

241 We also evaluated the efficacy of intravitreal injection using a

242 We evaluated the efficacy of islets isolated from 18- to 24

243 This trial evaluated the efficacy of maintenance erlotinib, an epid

244 In this study we evaluated the efficacy of mefloquine IPTp against S. hae

245 We evaluated the efficacy of MK-1775 alone or in combinatio

246 This phase 1/2 study evaluated the efficacy of mogamulizumab, a defucosylated

247 blind, placebo-controlled, phase 2 trial, we evaluated the efficacy of mongersen for the treatment of

248 In this prospective observational study, we evaluated the efficacy of on-demand approach.

249 In this study, we have evaluated the efficacy of our method for retrieval of DN

250 This study evaluated the efficacy of pediatric-like acute lymphobla

251 We further evaluated the efficacy of penfluridol in three different

252 In this study, we evaluated the efficacy of PENFS in adolescents with abdo

253 We evaluated the efficacy of regular provitamin A carotenoi

254 Remission in Depressed Elderly (PRIDE) study evaluated the efficacy of right unilateral ultrabrief pu

255 We evaluated the efficacy of small-quantity, lipid-based nu

256 In this phase 2 multicenter trial, we evaluated the efficacy of the combination of bortezomib,

257 We evaluated the efficacy of the potent antioxidant C3 to s

258 We evaluated the efficacy of thermal inactivation (exposure

259 We evaluated the efficacy of TM-2-51 on SH-SY5Y and BE(2)-C

260 We further evaluated the efficacy of tofacitinib as induction and m

261 We evaluated the efficacy of treatment with neratinib in pa

262 e or symptomatic urinary tract infection, we evaluated the efficacy of trimethoprim-sulfamethoxazole

263 This study evaluated the efficacy of twice- and thrice-weekly intra

264 This study evaluated the efficacy of videoendoscopy in visualizing

265 This study evaluates the efficacy of designer receptors exclusively

266 This systematic review evaluates the efficacy of patient navigation in improvin

267 strate application of the C-dot-hydrogel for evaluating the efficacy of a chemotherapeutic substance,

268 Currently available data evaluating the efficacy of antifungal prophylaxis strate

269 The role of the DDTs used for evaluating the efficacy of antituberculosis drug combina

270 Given that the "gold standard" for evaluating the efficacy of behavioral interventions is b

271 Our analysis of data from a clinical trial evaluating the efficacy of chemotherapy plus/minus trast

272 d a broad and accurate in vitro approach for evaluating the efficacy of commercial sunscreens even un

273 ental measurements are also ideal for use in evaluating the efficacy of competing theoretical approac

274 context for observed population changes when evaluating the efficacy of conservation management plans

275 Pilot studies are evaluating the efficacy of dual therapy with dolutegravi

276 GELA designed a randomized phase 2 trial evaluating the efficacy of either rituximab, doxorubicin

277 mp Abs will be an important consideration in evaluating the efficacy of gonococcal vaccine candidates

278 olled, randomized, fixed-dose clinical trial evaluating the efficacy of GSK561679, a corticotropin-re

279 Animal models are crucial for evaluating the efficacy of influenza vaccines.

280 tant measure for monitoring the epidemic and evaluating the efficacy of intervention and prevention t

281 re-activity relationship (SAR) was explored, evaluating the efficacy of its analogs in blocking 4-(me

282 erability of topical preparations as well as evaluating the efficacy of neuromodulator injections, or

283 c Abeta oligomers are potentially useful for evaluating the efficacy of new drugs and ultimately for

284 These findings may serve a benchmark role in evaluating the efficacy of novel interventions for cALD.

285 MRAs on SCD in usual care as well as studies evaluating the efficacy of other therapies to prevent SC

286 ack of randomized controlled clinical trials evaluating the efficacy of prismatic treatments for hemi

287 re searched for randomized controlled trials evaluating the efficacy of smoking cessation pharmacothe

288 tor cells treatment, further clinical trials evaluating the efficacy of the intervention in an earlie

289 ween eyes may prove useful for investigators evaluating the efficacy of unilateral treatments for RP

290 We evaluated the efficacy, potency, and selectivity of the

291 es associated risk factors and genotype, and evaluates the efficacy rate of quinacrine in those with

292 risk for developing subclinical AF and will evaluate the efficacy, safety, and economic value of ora

293 This study's aim was to evaluate the efficacy, safety, and local tolerability of

294 We sought to evaluate the efficacy, safety, and tolerability of intra

295 ective clinical study which was conducted to evaluate the efficacy, safety, predictability, ocular ab

296 The authors evaluated the efficacy, safety, and tolerability of cari

297 This phase 3 study further evaluated the efficacy, safety, and tolerability of valb

298 This study evaluates the efficacy, safety, and tolerability of regi

299 Without well-designed studies evaluating the efficacy, safety and cost-effectiveness o

300 This study was aimed to evaluate the efficacy, visual outcome and complications